In this 12-week , double-blind , placebo-controlled trial , 40 patients with Diagnostic and Statistical Manual of Mental Disorders-IV-TR BED and a comorbid current depressive disorder received duloxetine ( N = 20 ) or placebo ( N = 20 ) .
